 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies
|
|
|
|
Phase III, Phase II
|
|
|
|
CA184-025
NCT00162123
|
|
| |
Adesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma
|
|
|
|
Phase III
|
|
|
|
CCCGHS-NCI-T98-0085
NCI-T98-0085, NCI-99-C-0051B, T98-0085, NCT00019682
|
|
| |
A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma
|
|
|
|
Phase III
|
|
|
|
11718
NCT00111007
|
|
| |
Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
|
|
|
|
Phase III
|
|
|
|
NCI-06-C-0088
NCI-P6701, NCT00324727
|
|
| |
A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma
|
|
|
|
Phase III
|
|
|
|
LX01-315
NCT00395070
|
|
| |
M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma
|
|
|
|
Phase III
|
|
|
|
A/100/0402
NCT00477906
|
|
| |
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
|
|
|
|
Phase III
|
|
|
|
4783-08
NCT00522834
|
|
| |
Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
|
|
|
|
Phase III
|
|
|
|
AGENDA
GM307, NCT00518895
|
|
| |
Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases
|
|
|
|
Phase III
|
|
|
|
NCCTG-N06C6
N06C6, NCT00540969, NCCTG-N06C6
|
|
| |
PS-341 With Oral Temozolomide in Patients With Advanced Refractory Solid Tumors or Melanoma
|
|
|
|
Phase II, Phase I
|
|
|
|
2333
PHI 0241, NCT00209248
|
|
